References
- Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263.
- Detry O, Troisfontaine F, Meurisse N, et al. Prise en charge multidisciplinaire des tumeurs malignes primitives du foie. Rev Med Liege. 2021;76(5-6):519–524.
- Chedid MF, Kruel CRP, Pinto MA, et al. Hepatocellular carcinoma: diagnosis and operative management. Arq Bras Cir Dig. 2017;30(4):272–278. doi:10.1590/0102-6720201700040011.
- Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med. 2016;67(1):103–117. doi:10.1146/annurev-med-090514-013832.
- International Agency for Research on Cancer. GLOBOCAN 2020: estimated number of incident cases and deaths of cancer in 2020, worldwide, both sexes, all ages. Lyon: International Agency for Research on Cancer. 2020 [cited 2021 Sep 25]. https://gco.iarc.fr/today/home
- Tempia-Caliera AA, Ksontini R, Moradpour D, et al. Le carcinome hépatocellulaire: une approche multidisciplinaire [hepatocellular carcinoma: a multidisciplinary approach]. Rev Med Suisse. 2005;1(24):1621–1629.
- Desai A, Sandhu S, Lai JP, et al. Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review. World J Hepatol. 2019;11(1):1–18. doi:10.4254/wjh.v11.i1.1.
- Schütte K, Schulz C, Poranzke J, et al. Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver. BMC Gastroenterol. 2014;14:117. doi:10.1186/1471-230X-14-117.
- Zhang Y, Wang C, Xu H, et al. Hepatocellular carcinoma in the noncirrhotic liver: a literature review. Eur J Gastroenterol Hepatol. 2019;31(7):743–748. doi:10.1097/MEG.0000000000001419.
- Alkofer B, Lepennec V, Chiche L. Hepatocellular cancer in the non-cirrhotic liver. J Visc Surg. 2011;148(1):3–11. doi:10.1016/j.jviscsurg.2010.12.012.
- European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
- Allaire M, Goumard C, Lim C, et al. New frontiers in liver resection for hepatocellular carcinoma. JHEP Rep. 2020;2(4):100–134.
- Chiche L, Menahem B, Bazille C, et al. Recurrence of hepatocellular carcinoma in noncirrhotic liver after hepatectomy. World J Surg. 2013;37(10):2410–2418. doi:10.1007/s00268-013-2127-1.
- Heil J, Korenblik R, Heid F, et al. Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis. Br J Surg. 2021;108(7):834–842. doi:10.1093/bjs/znaa149.
- Korenblik R, van Zon JF, Olij B, et al. Resectability of bilobar liver tumours after simultaneous portal vein embolization versus portal vein embolization alone: meta-analysis. BJS Open. 2022;6(6):zrac141.2. doi:10.1093/bjsopen/zrac141.
- Schielke A, Meurisse N, Lamproye A, et al. Selection criteria for liver transplantation in patients with hepatocellular carcinoma. Eastern and Western experiences, and perspective for the future. Acta Gastroenterol Belg. 2019;82(2):314–318.
- Mergental H, Adam R, Ericzon B-G, et al. Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol. 2012;57(2):297–305. doi:10.1016/j.jhep.2012.03.022.